⌘K

Login Start Free

Home/Filings/4/0001209191-22-021454

4//SEC Filing

Pienta Kenneth 4

Accession 0001209191-22-021454

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 4:12 PM ET

Size

5.4 KB

Accession

0001209191-22-021454

Insider Transaction Report

Form 4

Period: 2022-03-25

Cue Biopharma, Inc.CUE

Chief Medical Officer

Transactions

Award
Stock Option (right to buy)
2022-03-25+40,000→ 40,000 total
Exercise: $5.01Exp: 2032-03-24→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0001571862

Filing Metadata

Form type: 4
Filed: Mar 28, 8:00 PM ET
Accepted: Mar 29, 4:12 PM ET
Size: 5.4 KB

View on SEC.gov